Loading the public record
Loading the public record
Where They Stand is a nonpartisan guide to everyone running for Congress: their money, their own words and how incumbents voted. Find your ballot →
All recent votes117th CongressHouse
Food and Drug Amendments of 2022
This bill reauthorizes Food and Drug Administration (FDA) user fee programs for certain drugs and devices, establishes requirements to increase diversity in clinical trials, and modifies requirements relating to the overall supply chain for drugs and devices.
Specifically, the bill reauthorizes through FY2027 the FDA user fee programs for prescription drugs, medical devices, generic drugs, and biosimilars.
The bill also requires the development of action plans and related reporting to increase the diversity of participants in clinical trials.
In addition, the bill requires the FDA to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why).
The bill also (1) establishes requirements and reauthorizes programs to support the development of specific categories of drugs and devices (e.g., pediatric drugs) and inspections of drug manufacturing facilities; and (2) establishes and revises requirements relating to the approval of drugs and devices, including requirements for postapproval studies and guidance about using real-world evidence to support drug and device applications.
Written by the nonpartisan Congressional Research Service, describing H.R. 7667 as passed House on Jun 8, 2022. It is not the text of the measure; a later amendment may have changed what it does.
House Jun 8, 2022
Food and Drug Amendments of 2022
Passed · Two-thirds required
392 Yea 28 Nay 7 not voting
Crossed both parties 28 of 420 voting members broke with their own party: 28 Republicans.
DemocratsRepublicansFilled: YeaRing: NayGrey: not voting or present
427 members on this roll call, from the official House record. Party majorities need at least five voting members, so an independent never counts as breaking with a party.
Signing on is not a vote: a member can cosponsor H.R. 7667 and vote against it. 3 signed when it was filed.
Organizations that named H.R. 7667 in a lobbying disclosure. Only those that cited the bill by number appear, so this is a floor, not a full list.
714 disclosures name this measure. Retrieved from LDA.gov on 2026-10-05. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.